Latest News

  • Sight Diagnostics Receives FDA Clearance For Blood Test Device

    Diagnostics World News | Sight Diagnostics' AI-based blood diagnostics device—called OLO—recently received 510(k) clearance for the US Food and Drug Administration (FDA), allowing the device to be marketed and sold in the US.

    Dec 6, 2019
  • Veracyte Acquires nCounter Platform For Diagnostics

    Diagnostics World News | Veracyte announced today that it has executed a definitive agreement with NanoString for the exclusive global license to the nCounter platform for diagnostic use as well as other tests for $40 million in cash and $10 million in stock.

    Dec 3, 2019
  • Proscia, Vela, Certara, and More: News From November 2019

    Diagnostics World News | November featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Proscia, Vela, Certara, and more.

    Nov 27, 2019
  • Research Unraveling The Mysteries of the Human Placenta

    Diagnostics World News | Researchers recently took a step towards unraveling the "black box" of pregnancy with a new imaging technique called pseudo-continuous arterial spin labeling magnetic resonance imaging (pCASL MRI), which tracks maternal blood flow to the placenta.

    Nov 26, 2019
  • Follow The Money: Investments and Funding Rounds for November

    Diagnostics World News | Some of the latest funding updates from across life sciences, clinical trials, the diagnostics industries.

    Nov 22, 2019
  • Scaling Precision Oncology

    Diagnostics World | Kenna Mills-Shaw believes that precision oncology is neither an illusion nor a panacea. But while there have been some dramatic wins for specific, molecularly-defined tumors, scaling precision oncology will require a highly integrated decision support platform.

    Nov 19, 2019
  • Machine Learning Takes On Sepsis

    Diagnostics World News | An early-stage startup is endeavoring to help clinical teams deliver high-value critical care with precision, and its first target is sepsis.

    Nov 18, 2019
  • Machine Learning Improves Detection of AKI in Burn Patients

    Diagnostics World News | A machine learning algorithm that contains the novel biomarker neutrophil gelatinase-associated lipocalin looks like a big win for patients with severe burns. It can help predict acute kidney injury close to two days before clinical symptoms are detectable by conventional diagnostic measures alone.

    Nov 15, 2019
  • Checklists Aid Development of ‘Clinically Ideal’ Point-Of-Care Tests

    Diagnostics World News | Point-of-care testing devices are getting smarter, but better planning on the front end can mean fewer disappointments for technology developers trying to win market acceptance of their products and care providers hoping to use them in real-world practice settings.

    Nov 13, 2019
  • Tackling The Signal-To-Noise Problem With Rare Cells And Exosomes

    Diagnostics World News | Advances in microfluidic cell sorting techniques at the University of Washington is allowing for highly precise isolation and analysis of tumor-derived rare cells and extracellular vesicles at high- throughput speed.

    Nov 12, 2019
  • Exosomes Start To Prove Their Worth in Cancer Management

    Diagnostics World News | Massachusetts General Hospital has developed liquid biopsy technologies to do high-throughput exosome protein profiling and point-of-care exosome analysis.

    Nov 8, 2019
  • Electrokinetic Chip Quickly Deep-Dives For Cancer Clues

    Diagnostics World News | Exosomes are promising targets for liquid biopsy diagnostics, but they’ve proven difficult to quickly capture and analyze. Oregon Health & Science University scientists are helping to overcome this hurdle with an alternating current electrokinetic microarray chip that integrates the isolation and analysis of exosomes and cell-free DNA biomarkers from a drop of blood.

    Nov 6, 2019
  • New-To-Market Tales of Two POC Diagnostic Products

    Diagnostics World News | Companies looking to commercialize rapid diagnostics technologies might want to borrow from the playbook of those who successfully brought their point-of-care (POC) products to market.

    Nov 5, 2019
  • Precision Oncology Facing Inequities and Acceptance Issues

    Diagnostics World News | Precision medicine promises treatment strategies tailored to individual patient characteristics and tumor biology. But improved health outcomes won’t happen without access to healthcare and molecular testing, which can differ substantially by geography and even within individual countries.

    Nov 1, 2019
  • Illumina, QIAGEN, Optibrium, and More: News From October 2019

    Diagnostics World News | October featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Illumina, QIAGEN, Optibrium, and more.

    Oct 31, 2019
  • Overcoming Obstacles With Liquid Biopsies

    Diagnostics World News | The value of liquid biopsies in precision medicine, particularly for managing cancers where tissue samples from tumors and metastatic sites are hard if not impossible to obtain, is a major topic of conversation, as tests that look for circulating tumor cells and circulating tumor DNA are enjoying a "resurgence" in clinical trials.

    Oct 29, 2019
  • Dopamine Detection Device Offers Faster and Direct Detection

    Diagnostics World News | The world of medicine is continually seeking new methods to improve health outcomes through a variety of innovative mechanisms, and accelerated diagnostics is no exception. Now, scientists may have a faster, easier way to diagnose and catch certain diseases earlier thanks to a new dopamine detector.

    Oct 24, 2019
  • Mixed Opinions On How To Regulate Laboratory Developed Tests

    Diagnostics World News | A trio of sessions at the 2019 Next Generation Dx Summit in August focused on laboratory developed tests (LDTs)—in vitro diagnostic tests designed, manufactured and used within a single laboratory—and incited lively debate about proposed regulation under the VALID Act.

    Oct 22, 2019
  • Engineered Viruses Could Fight Drug Resistance

    MIT News | MIT biological engineers can program bacteriophages to kill different strains of E. coli by making mutations in the protein that the viruses use to bind to host cells. These engineered phages are less likely to provoke resistance in bacteria, and could help to overcome antibiotic resistance.

    Oct 21, 2019
  • Sensors in Diagnostics: A Preview of the Sensors Summit

    Diagnostics World News | Sensors are revolutionizing healthcare and the presenters at the Sensors Summit 2019 are taking three days to show just how much.

    Oct 17, 2019